Analyzing ROI's for Rx Drugs to increase revenues

This paper describes an independent study which examined the rate of return on investment for four of the most frequently used promotional tactics in the pharmaceutical industry.

analyzing rOI's for rx drugs to increase revenues

Results show reallocating funds to advertising in medical publications can improve revenues and ROIs

Arthur M. MahoneyBay Head Consulting Group

Prescription pharmaceutical marketers have a number of promotional tactics available to help generate brand awareness and prescriptions. Four primary promotional tactics alone accounted for an estimated $11 billion in promotional expenditures during 2000. Detailing, or sales calls (excluding samples), accounted for $6 billion of that amount, $2.5 billion was spent on direct-to-consumer advertising, just over $0.5 billion was allocated to advertising in medical publications, and $1.9 billion was for physician meetings...

Not a subscriber?

Schedule your live demo with our team today

WARC helps you to plan, create and deliver more effective marketing

  • Prove your case and back-up your idea

  • Get expert guidance on strategic challenges

  • Tackle current and emerging marketing themes

We’re long-term subscribers to WARC and it’s a tool we use extensively. We use it to source case studies and best practice for the purposes of internal training, as well as for putting persuasive cases to clients. In compiling a recent case for long-term, sustained investment in brand, we were able to support key marketing principles with numerous case studies sourced from WARC. It helped bring what could have been a relatively dry deck to life with recognisable brand successes from across a broad number of categories. It’s incredibly efficient to have such a wealth of insight in one place.

Insights Team
Bray Leino

You’re in good company

We work with 80% of Forbes' most valuable brands* and 80% of the world's top top-of-the-class agencies.

* Top 10 brands